AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals™, Inc. today announced expansion plans for its Cedar Park (Greater Austin), Texas R&D center to include clinical manufacturing operations for ophthalmic and intranasal drug delivery systems and pharmaceutical products under development by the company.
